Advancements in Gastroenterology: A Weekly Review
Gastroenterologia
Gut-Liver Crossroads: Unlocking New Pathways in Liver Disease Treatment
Let's dive into the emerging science reshaping liver disease management—from liver sinusoidal endothelial cells to the gut microbiota's role in fibrosis. Discover how therapies like Pien Tze Huang, dapagliflozin, and lanifibranor are changing the game, and why early intervention and personalized approaches matter more than ever.
Bibliography
- Chen T, Zhang H, Shan W, Zhou J, You Y. Liver sinusoidal endothelial cells in hepatic fibrosis: opportunities for future strategies. Biochem Biophys Res Commun. 2025 Jun 20;766:151881.
- Zhang X, Zhang L, Ji L, Liangpunsakul S, Zhang J, Hong F, et al. Pien Tze Huang plus entecavir improves hepatic fibrosis in Chinese patients with chronic hepatitis B. Phytomedicine. 2025 Jul;142:156741.
- Heneghan MA, Lohse AW. Update in clinical science: Autoimmune hepatitis. J Hepatol. 2025 May;82(5):926–37.
- Castanho Martins M, Dixon ED, Lupo G, Claudel T, Trauner M, Rombouts K. Role of PNPLA3 in hepatic stellate cells and hepatic cellular crosstalk. Liver Int. 2025 Apr;45(4):e16117.
- Li L, Liu Y, Wang K, Mo J, Weng Z, Jiang H, et al. Stem cell exosomes: new hope and future potential for relieving liver fibrosis. Clin Mol Hepatol. 2025 Apr;31(2):333–49.
- Cheng Z, Yang L, Chu H. The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD. J Adv Res. 2025 Jun;72:353–67.
- Lin J, Huang Y, Xu B, Gu X, Huang J, Sun J, et al. Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial. BMJ. 2025 Jun 4;389:e083735.
- Pastor-Vivero MD, Costa I Colomer J, Martín de Vicente C, Vicente-Santamaria S, Garcia Romero R, González Jiménez D, et al. Advances in the treatment of cystic fibrosis: CFTR modulators. An Pediatr (Engl Ed). 2025 May;102(5):503857.
- Liguori A, Zoncapè M, Casazza G, Easterbrook P, Tsochatzis EA. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025 Apr;10(4):332–49.
